Tag: NASDAQ:KBIO

FB Nasdaq FB Facebook
Finance

Drug Manufacturers Most Volatile: ITI Inc (NASDAQ:ITCI), TherapeuticsMD Inc (NYSEMKT:TXMD), KaloBios Pharmaceuticals (NASDAQ:KBIO), Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

ITI Inc (NASDAQ:ITCI), a Company on the leading edge of transforming vaccines, announced the preliminary results of a Phase IB study of JRC-LAMP-vax™, a novel immunotherapy designed to treat individuals with allergy to Japanese red cedar (“JRC”). The Company is pleased to report that the Phase IB has met and maintained all primary safety and secondary immunological end points that were observed at the conclusion … Continue reading Drug Manufacturers Most Volatile: ITI Inc (NASDAQ:ITCI), TherapeuticsMD Inc (NYSEMKT:TXMD), KaloBios Pharmaceuticals (NASDAQ:KBIO), Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

Jason Knox
Finance

Drug Manufacturer Most Volatile: KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), Zogenix (NASDAQ:ZGNX), Rigel Pharmaceuticals (NASDAQ:RIGL), GW Pharmaceuticals (NASDAQ:GWPH)

KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) presented at the 26th Annual ROTH Conference on Wednesday, March 12, 2014 in Laguna Niguel, Californi 8:00 – 8:30 AM. Pacific Time KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) stock performance was -5.03% in last session and finished the day at $3.02. Traded volume was 205,759.00million shares in the last session and the average volume of the stock remained 355.36K shares. KaloBios Pharmaceuticals Inc … Continue reading Drug Manufacturer Most Volatile: KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), Zogenix (NASDAQ:ZGNX), Rigel Pharmaceuticals (NASDAQ:RIGL), GW Pharmaceuticals (NASDAQ:GWPH)

Jayne Crisman
Finance

Active Stocks : Halcon Resources (NYSE:HK), Concert Pharmaceuticals(NASDAQ:CNCE), Eastman Chemical (NYSE:EMN), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Tech Data Corp. (NASDAQ:TECD)

Halcon Resources Corp (NYSE:HK) last released its earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.04 by $0.03. The company had revenue of $327.10 million for the quarter, compared to the consensus estimate of $303.63 million. During the same quarter last year, the company posted $0.04 earnings per share. Halcon Resources … Continue reading Active Stocks : Halcon Resources (NYSE:HK), Concert Pharmaceuticals(NASDAQ:CNCE), Eastman Chemical (NYSE:EMN), KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO), Tech Data Corp. (NASDAQ:TECD)

Ryan Holtz